Natixis Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,085	Closed	-$2.1M	–	1693
2024 Q4	$2.1M	Buy	25,085 +502	+2%	+$41.3K	﹤0.01%	1082
2024 Q3	$1.8M	Sell	24,583 -7,077	-22%	-$532K	﹤0.01%	1119
2024 Q2	$2.17M	Sell	31,660 -3,592	-10%	-$249K	﹤0.01%	1022
2024 Q1	$2.44M	Buy	35,252 +1,364	+4%	+$93.7K	0.01%	974
2023 Q4	$2.43M	Buy	33,888 +2,554	+8%	+$147K	0.01%	946
2023 Q3	$1.63M	Sell	31,334 -2,510	-7%	-$146K	0.01%	1048
2023 Q2	$2.14M	Buy	33,844 +6,385	+23%	+$398K	0.01%	941
2023 Q1	$1.49M	Buy	27,459 +11	+0%	+$532	0.01%	1029
2022 Q4	$1.45M	Buy	27,448 +6,442	+31%	+$323K	0.01%	1033
2022 Q3	$977K	Buy	21,006 +2,099	+11%	+$110K	﹤0.01%	1117
2022 Q2	$1.08M	Buy	18,907 +742	+4%	+$42.1K	﹤0.01%	1103
2022 Q1	$1.11M	Buy	18,165 +7,558	+71%	+$393K	﹤0.01%	1099
2021 Q4	$555K	Buy	+10,607	New	+$446K	﹤0.01%	1231
2021 Q1	–	Sell	-10,758	Closed	-$342K	–	1302
2020 Q4	$342K	Buy	+10,758	New	+$283K	﹤0.01%	1166